This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Späth-Schwalbe, E. Articles by Born, J. Search for Related Content PubMed PubMed Citation Articles by Späth-Schwalbe, E. Articles by Born, J.

Acute Effects of Recombinant Human Interleukin-6 on Endocrine and Central Nervous Sleep Functions in Healthy Men¹

Department of Internal Medicine, Humboldt University (E.S.-S.), Charité, 10117 Berlin; Departments of Clinical Neuroendocrinology and Internal Medicine, University of Luebeck (K.H., F.S., L.M., H.L.F., J.B.), 23538 Luebeck; Department of Internal Medicine, University of Ulm (H.S.), 89081 Ulm; Sandoz Pharma Ltd. (K.B.), 90429 Nuernberg; and Department of Physiological Psychology, University of Bamberg (J.B.), 96045 Bamberg, Germany

Address all correspondence and requests for reprints to: Ernst Späth-Schwalbe, Universitätsklinikum Charité, Medizinische Klinik und Poliklinik II, Schumann-Straße 20/21, 10117 Berlin, Germany.

Interleukin-6 (IL-6) is a proinflammatory cytokine that has been shown to mediate, in addition to immune reactions, various endocrine and central nervous components of the acute phase response. In this context, the present study aimed to specify the contributions of IL-6 to the regulation of pituitary-adrenal secretory activity and GH and TSH secretion, as well as to the regulation of central nervous sleep and mood in healthy men. Effects of a low dose of IL-6 (0.5 µg/kg body weight) were assessed, inducing plasma IL-6 concentrations closely comparable with those typically observed after infectious challenge. Each of the 16 male subjects participated in two 14-h sessions (between 1800 and 0800 h), receiving either placebo or human recombinant IL-6 sc at 1900 h. Blood was collected repeatedly to determine plasma hormone levels, serum concentrations of cytokines, and C-reactive protein. Moreover, mood was assessed, and sleep recordings were obtained between 2300 and 0700 h. The cytokine induced a prolonged increase in plasma concentrations of ACTH and cortisol (P < 0.001), but led to a decrease in TSH concentrations (P < 0.01). In response to IL-6, subjects reported fatigue and felt more inactive and less capable of concentrating than after placebo. Sleep architecture was altered significantly by the cytokine. Slow-wave sleep was decreased during the first half and increased during the second half of sleep. Rapid eye movement sleep during the entire nocturnal sleep time was significantly decreased. After IL-6, body temperature rose slightly. C-reactive protein concentrations were dramatically increased 12.5 h after substance administration (P < 0.001). IL-6 did not affect serum concentrations of IL-2, IL-8, interferon-, and interferon-. The results underscore the importance of IL-6 in the cascade of cytokines for the neuroendocrine response during the acute phase reaction. In addition, IL-6 appears to be involved in changes of sleep and behavior accompanying infection and inflammatory disorders.

This article has been cited by other articles:

				J.-M. Dayer and E. Choy Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor Rheumatology, October 23, 2009; (2009) kep329v1. [Abstract] [Full Text] [PDF]

				C. Benedict, J. Scheller, S. Rose-John, J. Born, and L. Marshall Enhancing influence of intranasal interleukin-6 on slow-wave activity and memory consolidation during sleep FASEB J, October 1, 2009; 23(10): 3629 - 3636. [Abstract] [Full Text] [PDF]

				A. H. Miller, S. Ancoli-Israel, J. E. Bower, L. Capuron, and M. R. Irwin Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer J. Clin. Oncol., February 20, 2008; 26(6): 971 - 982. [Abstract] [Full Text] [PDF]

				T. Liukkonen, P. Rasanen, A. Ruokonen, J. Laitinen, J. Jokelainen, M. Leinonen, V. B. Meyer-Rochow, and M. Timonen C-reactive protein Levels and Sleep Disturbances: Observations Based on The Northern Finland 1966 Birth Cohort Study Psychosom Med, October 1, 2007; 69(8): 756 - 761. [Abstract] [Full Text] [PDF]

				S. Dimitrov, T. Lange, C. Benedict, M. A. Nowell, S. A. Jones, J. Scheller, S. Rose-John, and J. Born Sleep enhances IL-6 trans-signaling in humans FASEB J, October 1, 2006; 20(12): 2174 - 2176. [Abstract] [Full Text] [PDF]

				A. Collado-Hidalgo, J. E. Bower, P. A. Ganz, S. W. Cole, and M. R. Irwin Inflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors. Clin. Cancer Res., May 1, 2006; 12(9): 2759 - 2766. [Abstract] [Full Text] [PDF]

				N. Hiscock, C. P. Fischer, M. Sacchetti, G. van Hall, M. A. Febbraio, and B. K. Pedersen Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E2 - E7. [Abstract] [Full Text] [PDF]

				S. Alesci, P. E. Martinez, S. Kelkar, I. Ilias, D. S. Ronsaville, S. J. Listwak, A. R. Ayala, J. Licinio, H. K. Gold, M. A. Kling, et al. Major Depression Is Associated with Significant Diurnal Elevations in Plasma Interleukin-6 Levels, a Shift of Its Circadian Rhythm, and Loss of Physiological Complexity in Its Secretion: Clinical Implications J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2522 - 2530. [Abstract] [Full Text] [PDF]

				T. Rich, P. F. Innominato, J. Boerner, M. C. Mormont, S. Iacobelli, B. Baron, C. Jasmin, and F. Levi Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer Clin. Cancer Res., March 1, 2005; 11(5): 1757 - 1764. [Abstract] [Full Text] [PDF]

				A Hartkamp, R Geenen, M Bijl, A A Kruize, G L R Godaert, and R H W M Derksen Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome Ann Rheum Dis, October 1, 2004; 63(10): 1335 - 1337. [Abstract] [Full Text] [PDF]

				H. K. Meier-Ewert, P. M. Ridker, N. Rifai, M. M. Regan, N. J. Price, D. F. Dinges, and J. M. Mullington Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk J. Am. Coll. Cardiol., February 18, 2004; 43(4): 678 - 683. [Abstract] [Full Text] [PDF]

				M. D. Jensen Cytokine Regulation of Lipolysis in Humans? J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3003 - 3004. [Full Text] [PDF]

				A. N. Vgontzas, M. Zoumakis, E. O. Bixler, H.-M. Lin, P. Prolo, A. Vela-Bueno, A. Kales, and G. P. Chrousos Impaired Nighttime Sleep in Healthy Old Versus Young Adults Is Associated with Elevated Plasma Interleukin-6 and Cortisol Levels: Physiologic and Therapeutic Implications J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2087 - 2095. [Abstract] [Full Text] [PDF]

				L. Redwine, J. Dang, M. Hall, and M. Irwin Disordered Sleep, Nocturnal Cytokines, and Immunity in Alcoholics Psychosom Med, January 1, 2003; 65(1): 75 - 85. [Abstract] [Full Text] [PDF]

				Z A Erkut, E Endert, I Huitinga, and D F Swaab Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis Multiple Sclerosis, June 1, 2002; 8(3): 229 - 236. [Abstract] [PDF]

				E. M. Cassidy, D. Manning, S. Byrne, E. Bolger, F. Murray, N. Sharifi, E. Wallace, M. Keogan, and V. O'Keane Acute effects of low-dose interferon-{alpha} on serum cortisol and plasma interleukin-6 J Psychopharmacol, May 1, 2002; 16(3): 230 - 234. [Abstract] [PDF]

				H. K. Meier-Ewert, P. M. Ridker, N. Rifai, N. Price, D. F. Dinges, and J. M. Mullington Absence of Diurnal Variation of C-Reactive Protein Concentrations in Healthy Human Subjects Clin. Chem., March 1, 2001; 47(3): 426 - 430. [Abstract] [Full Text] [PDF]

				D. W Wilmore and H. Kehlet Recent advances: Management of patients in fast track surgery BMJ, February 24, 2001; 322(7284): 473 - 476. [Full Text]

				A. Schuld, J. Mullington, E. Friess, D. M. Hermann, C. Galanos, F. Holsboer, and T. Pollmächer Changes in Dehydroepiandrosterone (DHEA) and DHEA-Sulfate Plasma Levels during Experimental Endotoxinemia in Healthy Volunteers J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4624 - 4629. [Abstract] [Full Text]

				T. Kumpfel, F. T. Bergh, T. Pollmacher, F. Holsboer, and C. Trenkwalder Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS Neurology, October 24, 2000; 55(8): 1231 - 1233. [Abstract] [Full Text] [PDF]

				L. Redwine, R. L. Hauger, J. C. Gillin, and M. Irwin Effects of Sleep and Sleep Deprivation on Interleukin-6, Growth Hormone, Cortisol, and Melatonin Levels in Humans J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3597 - 3603. [Abstract] [Full Text]

				T.M. O'CONNOR, D.J. O'HALLORAN, and F. SHANAHAN The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia QJM, June 1, 2000; 93(6): 323 - 333. [Abstract] [Full Text] [PDF]

				J. Mullington, C. Korth, D. M. Hermann, A. Orth, C. Galanos, F. Holsboer, and T. Pollmacher Dose-dependent effects of endotoxin on human sleep Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R947 - R955. [Abstract] [Full Text] [PDF]

				A. Schuld, J. Mullington, D. Hermann, D. Hinze-Selch, T. Fenzel, F. Holsboer, and T. Pollmacher Effects of granulocyte colony-stimulating factor on night sleep in humans Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1149 - R1155. [Abstract] [Full Text] [PDF]